HOME >> MEDICINE >> NEWS
Emory Receives $14 Million Federal Grant To Coordinate 50-Site Brain Attack Prevention Trial

An Aspirin A Day To Keep Stroke Away?

Doctors don't know how best to prevent stroke caused by clogged arteries in the brain -- a condition known as intracranial arterial stenosis.

To better evaluate two potential tactics for preventing this type of stroke in high-risk patients, the National Institute of Neurological Disorders and Stroke of the National Institutes of Health has funded the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) study.

Emory University has been awarded more than $14 million from the institute to coordinate a five-year trial during which 806 patients will be evaluated at 50 sites in North America. The Clinical Coordinating Center will be based in the Department of Neurology at the Emory University School of Medicine, the Statistical Coordinating Center in the Department of Biostatistics at the Rollins School of Public Health of Emory University and the Pharmacy Coordinating Center at Emory University Hospital.

"This year we expect more than 700,000 Americans to experience a stroke, and of these, some 40,000 will sustain stroke caused by narrowing of the intracranial arteries," says WASID Principal Investigator Marc Chimowitz, M.B., ChB, associate professor and co-director of Emory Stroke Center in the Department of Neurology at the Emory University School of Medicine. "This type of stroke disproportionately affects minorities, including African-Americans, Asians and Hispanics.

"Our primary goal will be to compare the effectiveness of two different medications, warfarin or aspirin, for preventing stroke and vascular death in persons with intracranial stenosis," Dr. Chimowitz says.

Patients who have recently had a minor stroke or transient ischemic attack (TIA, or "mini stroke"), who are eligible to participate and sign an informed consent, will be randomized to receive either aspirin or warfarin, and will be evaluated by s
'"/>

Contact: Sarah Goodwin
sgoodwi@emory.edu
404-727-3366
Emory University Health Sciences Center
31-Mar-1999


Page: 1 2

Related medicine news :

1. Emory Study finds HIV is not an independent risk factor for severe heart disease
2. Emory cardiologists present research at AHA scientific sessions in New Orleans, Nov. 7 - 10
3. Emory study finds mental health and heart disease tightly linked
4. Emory conference to educate health professionals about metabolic syndrome
5. Emory researcher examines effects of antiepileptic drugs on pregnant women and their offspring
6. Emory researchers find race and gender gaps in treatment of heart attack
7. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
8. Emory and CDC scientists explore why most breastfed infants of HIV-positive mothers resist infection
9. Emory scientists find marker for long-term immunity
10. Emory scientists find oral tetrahydrobiopterin can reduce high blood pressure
11. Emory scientists link atrial fibrillation with decrease in nitrous oxide

Post Your Comments:
(Date:5/22/2013)... (PRWEB) May 22, 2013 Athletic-Minded ... and publishing company released today its 2013 U.S. ... business hotels received the company’s recommendation after ongoing ... anonymous personal tours by the editorial staff. ... lap pool, sport court, etc.), in-room workout choices, ...
(Date:5/21/2013)... 22, 2013 The University of Colorado’s ... with HEALTHY DINING to help Coloradans make healthier choices ... new program is called HEALTHY DINING IN COLORADO. ... already participating in Colorado. Restaurants will offer a selection ... emphasizing lean protein, vegetables, fruits, whole grains and unsaturated ...
(Date:5/21/2013)... (PRWEB) May 22, 2013 Swimsuit season is ... Cellulite Whisperer ® products has begun with a 35% discount. ... to estrogen. Many women get the dreaded cellulite even if ... beneath the skin where they have been stored as toxic ... are no easy fixes, a specific program that works to ...
(Date:5/21/2013)... Feed additives have now become an ... chain. Most of the feed additives are used in ... and powders. There are variety of feed additives available ... upon the type of animal and feed. Nutritional feed ... essential nutrition to the animal in order to gain ...
(Date:5/21/2013)... WASHINGTON (May 22, 2013)Today the George Washington ... Health Services (SPHHS) announced the launch of ... Immigrant/Refugee Health, a collaboration between SPHHS, the ... and other community partners. This university-community partnership ... disproportionately affect Latino communities through research, mutual ...
Breaking Medicine News(10 mins):Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 3Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4Health News:GW launches center to address health disparities in the Latino immigrant community 2Health News:GW launches center to address health disparities in the Latino immigrant community 3
(Date:5/22/2013)... BOTHELL, Wash. and VANCOUVER, British Columbia ... OGXI ), a leader in the development of ... today announced that four trials of its investigational compounds, custirsen ... at the 49 th Annual Meeting of the American ... from May 31 – June 4. ...
(Date:5/21/2013)... Mass. , May 21, 2013  NxStage Medical, ... of innovative dialysis products, today announced that it has ... critical care and in-center products to DaVita, the kidney ... http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) For the use ... United States , NxStage has executed a second ...
(Date:5/21/2013)... 21, 2013   Regulus Therapeutics Inc . ( ... and development of innovative medicines targeting microRNAs, today announced ... Chief Operating Officer and Executive Vice President, Finance, will ... Annual Healthcare Conference on Wednesday, May 29, 2013 at ... the Westin Boston Waterfront Hotel. The presentation ...
Breaking Medicine Technology:OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 4OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 5NxStage Announces New Agreements with DaVita 2Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference 2
Cached News: